Lateef Zameer
Overview
Explore the profile of Lateef Zameer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
25
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sarkar A, Parihar M, Zameer L, Bhave S, Nair R, Dey D
Indian J Hematol Blood Transfus
. 2022 Oct;
38(4):757-759.
PMID: 36258737
No abstract available.
2.
Dey D, Lali B, Roy P, Midha D, Arun I, Zameer L, et al.
Ecancermedicalscience
. 2022 Oct;
16:1441.
PMID: 36200017
A central review of histopathology specimens at tertiary oncology hospitals is important for optimum patient care in the modern era of personalised medicine. The challenges of healthcare delivery and access...
3.
Mishra A, Achari R, Zameer L, Achari G, Gehani A, Roy P, et al.
Neurol India
. 2022 May;
70(2):772-774.
PMID: 35532657
We report a case of a 9-year-old boy with glioblastoma with a past history of colon cancer. Germline bi-allelic DNA-mismatch repair deficiency was diagnosed by a lack of immunohistochemical staining...
4.
Achari R, Chakraborty S, Goyal L, Saha S, Roy P, Zameer L, et al.
JCO Glob Oncol
. 2022 Mar;
8:e2100405.
PMID: 35298293
Purpose: There are limited reports of quality metrics in glioblastoma. We audited our adherence to quality indicators as proposed in the PRIME Quality Improvement study. Methods: This is a retrospective...
5.
Roya P, Zameer L, Dey D, Datta J, Bardia A, Mishra D
Ecancermedicalscience
. 2022 Feb;
15:1337.
PMID: 35211206
Purpose: Tumour budding (TB) is an important adverse prognostic factor in colon cancer, which can also guide adjuvant treatment in stage II colorectal carcinoma. The International Tumor Budding Consensus Conference...
6.
Radhakrishnan V, Bajaj R, Raina V, Kumar J, Bhave S, Sukumaran Nair R, et al.
Front Oncol
. 2022 Feb;
11:796270.
PMID: 35127505
Introduction: Despite high cure rates with standard treatment, 30% patients with Hodgkin lymphoma develop relapsed or refractory (R/R) disease. Salvage therapy followed by autologous hematopoietic cell transplantation (HCT) is considered...
7.
Lamichhane R, Roy P, Hawkins C, Zameer L, Gehani A, Achari R, et al.
Pediatr Blood Cancer
. 2021 Dec;
69(5):e29520.
PMID: 34913598
No abstract available.
8.
Alphones S, Chatterjee U, Singh A, Das A, Zameer L, Achari R, et al.
Childs Nerv Syst
. 2021 Jun;
37(8):2521-2530.
PMID: 34097097
Purpose: Immunohistochemical (IHC) testing for mismatch repair (MMR) deficiency (MMRD) is used as a screening tool to identify microsatellite instability in various cancers (especially colon). This not only identifies hereditary...
9.
Das J, Ghosh J, Zameer L, Ray S
Indian J Nucl Med
. 2021 May;
36(1):56-58.
PMID: 34040299
Rhabdoid tumor commonly occurs in the kidney and has an aggressive clinical course with high mortality. Extrarenal rhabdoid tumours can involve a number of organs, but poorly differentiated follicular carcinoma...
10.
Roy P, Mallick I, Arun I, Zameer L, Dey D, Singh A, et al.
Oral Oncol
. 2020 Dec;
113:105115.
PMID: 33341004
Objectives: Nodal metastasis is an important prognostic factor in oral squamous cell carcinoma (OSCC). Detailed topographic study of metastasis can guide surgical and adjuvant radiation treatment protocols. Methods: Retrospective analysis...